iBio, Inc. (IBIO) financial statements (2022 and earlier)

Company profile

Business Address 600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,14596,97455,1124,42115,9348,08823,014
Cash and cash equivalents39,20577,40455,1124,42115,9348,08823,014
Short-term investments 19,570     
Other undisclosed cash, cash equivalents, and short-term investments5,940      
Receivables111426759775175606
Inventory, net of allowances, customer advances and progress billings1,986      
Inventory1,986      
Other undisclosed current assets20,2547,1976,561290276309286
Total current assets:67,496104,59761,7484,80816,2858,57223,906
Noncurrent Assets
Finance lease, right-of-use asset10926,11127,616
Operating lease, right-of-use asset5,291  
Property, plant and equipment32,8818,6283,65724,38025,15225,58925,574
Intangible assets, net (including goodwill)5,0419521,1441,3741,6201,8232,092
Intangible assets, net (excluding goodwill)5,0419521,1441,3741,6201,8232,092
Prepaid expense1,195      
Restricted cash and investments5,940      
Other undisclosed noncurrent assets8,4956,6802424262628
Total noncurrent assets:58,95242,37132,44125,77826,79827,43827,694
TOTAL ASSETS:126,448146,96894,18930,58643,08336,01051,600
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,5815,2552,8641,9661,8381,6732,097
Accounts payable2,7392,2541,7591,0017907491,177
Accrued liabilities2,8423,0011,1059651,048924920
Deferred revenue604231,810
Debt45967562213197183170
Contract with customer, liability1,279
Other undisclosed current liabilities2,660    15724
Total current liabilities:8,3466,6455,2363,4582,0352,0132,291
Noncurrent Liabilities
Long-term debt and lease obligation27,50431,75532,34624,67124,88425,08225,265
Long-term debt, excluding current maturities22,053 339    
Finance lease, liability5131,75532,007
Capital lease obligations24,67124,88425,08225,265
Operating lease, liability5,400  
Other undisclosed noncurrent liabilities(5,400)      
Total noncurrent liabilities:27,50431,75532,34624,67124,88425,08225,265
Total liabilities:35,85038,40037,58228,12926,91927,09527,556
Stockholders' equity
Stockholders' equity attributable to parent90,598108,58556,6182,46316,1668,9149,937
Common stock21821714020168989
Additional paid in capital284,957282,058206,931108,295104,40880,97767,468
Accumulated other comprehensive loss(91)(63)(33)(31)(30)(29)(29)
Accumulated deficit(194,486)(173,627)(150,420)(105,821)(88,228)(72,123)(57,591)
Stockholders' equity attributable to noncontrolling interest (17)(11)(6)(2)114,107
Total stockholders' equity:90,598108,56856,6072,45716,1648,91524,044
TOTAL LIABILITIES AND EQUITY:126,448146,96894,18930,58643,08336,01051,600

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues1,6352,3711,6382,018444394948
Revenue, net 394948
Cost of revenue
(Cost of Goods and Services Sold)
(833)(1,462)     
Gross profit:8029091,6382,018444394948
Operating expenses(38,056)(32,020)(15,641)(17,806)(14,671)(14,668)(10,841)
Operating loss:(37,254)(31,111)(14,003)(15,788)(14,227)(14,274)(9,893)
Nonoperating income (expense)8,8467,898(2,441)(1,809)(1,881)(1,865)(764)
Interest and debt expense(2,162)(2,454)(2,466)(1,900)(1,915)(1,929)(807)
Loss from continuing operations before income taxes:(30,570)(25,667)(18,910)(19,497)(18,023)(18,068)(11,464)
Income tax benefit 55     
Other undisclosed income from continuing operations55      
Loss before gain (loss) on sale of properties:(30,515)(25,612)(18,910)(19,497)(18,023)(18,068)(11,464)
Other undisclosed net income2,1072,3992,4661,9001,9151,929807
Net loss:(28,408)(23,213)(16,444)(17,597)(16,108)(16,139)(10,657)
Net income attributable to noncontrolling interest465431,607893
Net loss attributable to parent:(28,404)(23,207)(16,439)(17,593)(16,105)(14,532)(9,764)
Other undisclosed net loss available to common stockholders, basic(217)(260)(21,821)(260)(260)(90) 
Net loss available to common stockholders, diluted:(28,621)(23,467)(38,260)(17,853)(16,365)(14,622)(9,764)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss:(28,408)(23,213)(16,444)(17,597)(16,108)(16,139)(10,657)
Other undisclosed comprehensive loss(38)(30)(2)(1)(1) (4)
Comprehensive loss:(28,446)(23,243)(16,446)(17,598)(16,109)(16,139)(10,661)
Comprehensive income, net of tax, attributable to noncontrolling interest465431,607893
Comprehensive loss, net of tax, attributable to parent:(28,442)(23,237)(16,441)(17,594)(16,106)(14,532)(9,768)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: